CN1181819C - 使用五氟苯磺酰胺的综合疗法 - Google Patents

使用五氟苯磺酰胺的综合疗法 Download PDF

Info

Publication number
CN1181819C
CN1181819C CNB00810977XA CN00810977A CN1181819C CN 1181819 C CN1181819 C CN 1181819C CN B00810977X A CNB00810977X A CN B00810977XA CN 00810977 A CN00810977 A CN 00810977A CN 1181819 C CN1181819 C CN 1181819C
Authority
CN
China
Prior art keywords
cisplatin
compound
alkyl
treatment
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB00810977XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1367690A (zh
Inventor
S���ĵ���
S·施文德纳
P·蒂默曼斯
J·沃林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exmes Gen Sf Co ltd
Quest Discovery Ltd
Amgen Inc
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of CN1367690A publication Critical patent/CN1367690A/zh
Application granted granted Critical
Publication of CN1181819C publication Critical patent/CN1181819C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Weting (AREA)
CNB00810977XA 1999-07-29 2000-07-27 使用五氟苯磺酰胺的综合疗法 Expired - Fee Related CN1181819C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14643699P 1999-07-29 1999-07-29
US60/146,436 1999-07-29

Publications (2)

Publication Number Publication Date
CN1367690A CN1367690A (zh) 2002-09-04
CN1181819C true CN1181819C (zh) 2004-12-29

Family

ID=22517356

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB00810977XA Expired - Fee Related CN1181819C (zh) 1999-07-29 2000-07-27 使用五氟苯磺酰胺的综合疗法

Country Status (16)

Country Link
US (1) US6355628B1 (https=)
EP (1) EP1206256B8 (https=)
JP (1) JP2003505513A (https=)
KR (1) KR100685059B1 (https=)
CN (1) CN1181819C (https=)
AT (1) ATE294574T1 (https=)
AU (1) AU775305B2 (https=)
CA (1) CA2380078C (https=)
DE (1) DE60019937T2 (https=)
DK (1) DK1206256T3 (https=)
ES (1) ES2241639T3 (https=)
IL (2) IL147890A0 (https=)
PT (1) PT1206256E (https=)
RU (1) RU2268054C2 (https=)
WO (1) WO2001008693A2 (https=)
ZA (1) ZA200200889B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69724777T2 (de) * 1996-02-22 2004-07-15 Tularik, Inc., South San Francisco Pentafluorobenzensulfonamiden und analoge
PT939627E (pt) * 1996-07-19 2004-02-27 Tularik Inc Pentafluorobenzenossulfonamidas e analogos
ES2194547T3 (es) * 1998-09-23 2003-11-16 Tularik Inc Arilsulfonanilida-ureas.
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
WO2002039958A2 (en) 2000-11-03 2002-05-23 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
FR2834641B1 (fr) * 2002-01-14 2005-04-22 Ct Regional De Lutte Contre Le Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
WO2005051303A2 (en) * 2003-11-19 2005-06-09 Lixin Zhang Screening for synergistic compounds
US10238831B2 (en) 2013-09-08 2019-03-26 Qool Therapeutics, Inc. Temperature measurement and feedback for therapeutic hypothermia
CN107530187B (zh) 2015-02-23 2020-06-30 库尔诊疗公司 用于冷冻颗粒的气管内递送的系统
EP3676255B1 (en) 2017-08-29 2025-04-16 Rutgers, The State University University Of New Jersey Therapeutic indazoles
EP3684754A4 (en) * 2017-09-21 2021-06-02 Dalriada Therapeutics Inc. PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND ASSOCIATED USES

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
CH362688A (de) 1957-09-10 1962-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (nl) 1970-04-13 1984-07-16 Minnesota Mining & Mfg Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking.
SE447902B (sv) * 1977-10-19 1986-12-22 Johnson Matthey Co Ltd Cis-koordinationsforening av platina och komposition innehallande foreningen
DE3623184A1 (de) 1986-07-10 1988-01-14 Kali Chemie Ag Verfahren zur herstellung von n-fluorsulfonamiden
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
FR2645537B1 (fr) 1989-04-05 1994-03-04 Fabre Medicament Pierre Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique
FR2665440B1 (fr) 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
EP0472053B1 (en) 1990-08-20 1998-06-17 Eisai Co., Ltd. Sulfonamide derivatives
RU2088288C1 (ru) * 1993-07-29 1997-08-27 Московский областной научно-исследовательский клинический институт Способ лечения больных местнораспространенными формами рака
RU2098096C1 (ru) * 1993-10-11 1997-12-10 Московский научно-исследовательский онкологический институт им.П.А.Герцена Средства, подавляющие рост раковых клеток
WO1996040629A1 (en) 1995-06-07 1996-12-19 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
DE69724777T2 (de) 1996-02-22 2004-07-15 Tularik, Inc., South San Francisco Pentafluorobenzensulfonamiden und analoge
PT939627E (pt) * 1996-07-19 2004-02-27 Tularik Inc Pentafluorobenzenossulfonamidas e analogos
CZ298022B6 (cs) * 1996-10-15 2007-05-30 G. D. Searle & Co. Použití inhibitoru cyklooxygenázy-2 pro výrobu léciva pro lécení a prevenci neoplazie
JP2001505564A (ja) * 1996-11-19 2001-04-24 ジー．ディー．サール アンド カンパニー 抗血管新生剤としてのシクロオキシゲナーゼ―２阻害剤の使用方法
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
ATE248845T1 (de) * 1998-06-25 2003-09-15 Tularik Inc Arylsulfonanilid-phosphate
ES2194547T3 (es) * 1998-09-23 2003-11-16 Tularik Inc Arilsulfonanilida-ureas.
AU2190700A (en) * 1998-12-17 2000-07-03 Tularik Inc. Tubulin-binding agents
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular

Also Published As

Publication number Publication date
CA2380078C (en) 2008-05-06
EP1206256B1 (en) 2005-05-04
EP1206256B8 (en) 2005-06-29
WO2001008693A3 (en) 2001-05-25
ZA200200889B (en) 2003-03-26
US6355628B1 (en) 2002-03-12
KR20020050225A (ko) 2002-06-26
DK1206256T3 (da) 2005-08-15
ES2241639T3 (es) 2005-11-01
CA2380078A1 (en) 2001-02-08
AU6615200A (en) 2001-02-19
PT1206256E (pt) 2005-09-30
EP1206256A2 (en) 2002-05-22
AU775305B2 (en) 2004-07-29
RU2002105374A (ru) 2004-01-10
KR100685059B1 (ko) 2007-02-22
JP2003505513A (ja) 2003-02-12
CN1367690A (zh) 2002-09-04
IL147890A (en) 2007-07-04
WO2001008693A2 (en) 2001-02-08
RU2268054C2 (ru) 2006-01-20
DE60019937T2 (de) 2006-05-04
IL147890A0 (en) 2002-08-14
ATE294574T1 (de) 2005-05-15
DE60019937D1 (de) 2005-06-09

Similar Documents

Publication Publication Date Title
RU2425041C2 (ru) Кристаллические и другие формы солей, образованных из молочной кислоты и 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1н-бензимидазол-2-ил]-1н-хинолин-2-она
CN1703223A (zh) 喹唑啉衍生物 z d 6 4 7 4组合吉西他滨并任选组合电离辐射在治疗与血管生成和 /或血管通透性增加相关的疾病中的用途
CN1181819C (zh) 使用五氟苯磺酰胺的综合疗法
KR20170131650A (ko) 글루타미나제 억제제의 투여 방법
CN1360503A (zh) 用于治疗癌症的海鞘素743的组合物和用途
CA2836385A1 (en) Method for treatment of advanced solid tumors
JP2021512110A (ja) ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法
JP5514123B2 (ja) 卵巣癌を治療するための、パクリタキセルを含む配合剤
CN1798561A (zh) 海鞘素－743和铂抗肿瘤化合物的联合应用
CN1283248C (zh) 包含埃坡霉素的组合及其药学应用
CN1265786C (zh) 式ⅰ的化合物和紫杉醇在制备用于治疗癌症疾病的药物中的用途
CN1897949A (zh) 包含使用et－743和紫杉醇来治疗癌症的联合疗法
JPWO2021093839A5 (https=)
US6822001B2 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
JP2023509191A (ja) 癌を治療するための組み合わせ療法
JP2010530411A (ja) 白金（ｉｖ）錯体
JP2023050198A (ja) ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法
AT505367A1 (de) Tumorhemmende ruthenium und osmium- thiosemicarbazonatokomplexe
TWI307628B (en) Use of zd0473 in combination with a non-platinum based anti-cancer agent
KR20240159340A (ko) 폐섬유화 예방 또는 치료를 위한 펙시다티닙 및 닌테다닙의 병용 요법
CN121419773A (zh) 用于预防或治疗肺纤维化的达可替尼和尼达尼布的联合疗法
KR20230147351A (ko) 퀴녹살린 카르복스아마이드 유도체 및 이를 유효성분으로 포함하는 교모세포종의 예방 또는 치료용 약학적 조성물
CN1780629A (zh) 含有n－(3－氯－1h－吲哚－7－基)－4－氨磺酰基苯磺酰胺和另一种细胞毒药物的药物组合
HK40040206A (en) Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
JP2012511554A (ja) Ａｖｅ８０６２およびドセタキセルを組み合わせる抗腫瘍組み合わせ

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: AMGEN CO., LTD.

Free format text: FORMER OWNER: AMGEN INC

Effective date: 20060922

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: AMGEN INC

Free format text: FORMER NAME OR ADDRESS: LLANO EXPLORATION LTD.

Owner name: LLANO EXPLORATION LTD.

Free format text: FORMER NAME OR ADDRESS: FIGURE LARIC CO., LTD.

CP03 Change of name, title or address

Address after: Delaware

Patentee after: Exmes Gen SF Co.,Ltd.

Address before: Delaware

Patentee before: Quest discovery Ltd.

Address after: Delaware

Patentee after: Quest discovery Ltd.

Address before: California, USA

Patentee before: Tularik Inc.

TR01 Transfer of patent right

Effective date of registration: 20060922

Address after: California, USA

Patentee after: AMGEN Inc.

Address before: Delaware

Patentee before: Exmes Gen SF Co.,Ltd.

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041229

Termination date: 20090727